Purple biotech reports first quarter 2022 financial results

Rehovot, israel, may 12, 2022 (globe newswire) -- purple biotech ltd. ("purple biotech", or the "company") (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced financial results for the first quarter ended march 31, 2022.

PPBT Ratings Summary

PPBT Quant Ranking